Prostate Cancer Genomic Test | Prolaris® for AS Decisions
Sponsored The Prolaris® Test delivers clarity into intermediate-risk prostate cancer decision-making. …Predict tumor aggression · Free patient ready pack · Measure tumor growth · Increased patient safety
Types: DNA health testing, Prostate cancer treatment, New therapy, Active surveillance
